Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
2018 ◽
Vol 36
(4)
◽
pp. 505-505
Amir Ansaripour
◽
Carin A. Uyl-de Groot
◽
W. Ken Redekop
2018 ◽
Vol 36
(3)
◽
pp. 381-382
Amir Ansaripour
◽
Carin A. Uyl-de Groot
◽
W. Ken Redekop
2017 ◽
Vol 36
(1)
◽
pp. 91-103
◽
Amir Ansaripour
◽
Carin A. Uyl-de Groot
◽
W. Ken Redekop
2011 ◽
Vol 14
(3)
◽
pp. A165
T.T.T. Nguyen
◽
R. Yagudina
◽
A.U. Kulikov
2014 ◽
Vol 17
(7)
◽
pp. A735
◽
Vineeth Tatineni
◽
Daniel Redle
◽
Daljeet Singh
◽
Arifa Abid
◽
Sameer Mahesh
2011 ◽
Vol 29
(15_suppl)
◽
pp. 575-575
◽
I. Lang
◽
R. Bell
◽
F. Feng
◽
R. I. Lopez
◽
J. Jassem
◽
...
2014 ◽
Vol 18
(3)
◽
pp. 173-188
◽
C. L. Attard
◽
A. N. Pepper
◽
S. T. Brown
◽
M. F. Thompson
◽
P.-O. Thuresson
◽
...
2010 ◽
Vol 19
(sup1)
◽
pp. S31-S39
◽
Otto Metzger-Filho
◽
Tushar Vora
◽
Ahmad Awada
2018 ◽
Vol 36
(3)
◽
pp. 383-384
Noga Gershon
◽
Yakir Berchenko
2013 ◽
Vol 16
(3)
◽
pp. A128
Y. Xia
◽
B. Bian
◽
E. Costea
◽
C.M. Kelton
◽
J.J. Guo
Close
Export Citation Format
Close
Share Document
Close